A normal ionized calcium (iCa) concentration in blood is important to many fundamental physiologic regulatory mechanisms (1) (2) (3) (4) (5) . However, abnormalities of iCa concentration are common in critically ill patients (6 -9) . The vast majority of these abnormalities are due to hypocalcemia (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) , but hypercalcemia has also been reported (25) .
Hypocalcemia has been associated with increased mortality in critically ill patients (5, 7, 10 -17, 23, 24, 26) . However, this relationship is derived from univariate analyses or relatively small single center studies (7, 10 -17) . Additionally, there are only a few small studies on the association between hypercalcemia and mortality in critically ill patients (1, 27) . Thus, the independent relationship between abnormalities of iCa and outcome is currently poorly understood.
Despite this limitation, correction of hypocalcemia with exogenous calcium has been advocated to prevent neurologic and cardiovascular complications (28, 29) . However, the administration of exogenous calcium may have complications. For example, increased mortality was reported in models of sepsis (30) . Thus, clinicians are left with uncertainty about the therapeutic implications of disorders of iCa homeostasis.
Accordingly, we sought to assess the independent relationship among intensive care unit (ICU) admission (iCa Adm ); maximal (iCa Max ); minimal (iCa Min ), and timeweighted average of (iCa Tw ) blood iCa concentration and ICU or hospital mortality in a large multicenter heterogeneous cohort of ICU patients.
MATERIALS AND METHODS
The data collection for this study was part of an established quality assurance activity. The data collection and the data analysis for this study were approved by the local institutional ethic committee, which waived the need for informed consent. The Austin Hospital Ethics Committee approved this investigation and its submission for publication.
Study Population and Data Sources. The current study is a multicenter, retrospective, and observational investigation of 7024 ICU patients. Four hospitals, three in Melbourne and one in Sydney, Australia participated in this study. All patients admitted to the ICUs of these hospitals from February 2, 2000 to October 20, 2004 were included. Patients admitted during periods when arterial blood gas data were not electronically stored in a given hospital were excluded. Patients who required renal replacement therapy by using citratebased anticoagulation were excluded (31) .
Age, sex, use of mechanical ventilation, reason for ICU admission, and Acute Physiology and Chronic Health Evaluation II score (32) were obtained from the electronic data repositories of each ICU, using data that had been collected prospectively by trained data collectors. Coding for admission diagnosis was by means of a modified Acute Physiology and Chronic Health Evaluation III system used by the Australian and New Zealand Intensive Care Society (33) . The Australian and New Zealand Intensive Care Society Centre for Outcome and Resources Evaluation independently collected information on clinical outcomes. The Australian and New Zealand Intensive Care Society Centre for Outcome and Resources Evaluation Adult Patient database is a highquality database whose features have been previously described (34) .
iCa Concentration Measurements. All iCa concentrations in the ICU were measured by arterial blood gas analyzer (Rapilab, Bayer, Sydney, Australia). The iCa data for this study were corrected to a pH of 7.4. The iCa data reported in this study were stored and retrieved electronically. Blood samples were collected in standard preprepared, heparinized blood gas syringes. The analyzer measured whole-blood samples at 37°C. Trained nursing staff performed all blood analysis. Laboratories in the participating hospitals comply with standards of the National Association of Testing Authorities (35) and the Royal College of Pathologists of Australia (36) . The characteristic of the systems are the following: mean SD: 0.009; mean coefficient of variation (SD/mean): 0.008; average bias: 0.041.
iCa Max and iCa Min calcium concentrations were obtained, each indicating the highest or lowest value recorded while in ICU. In addition, to avoid the potential surveillance bias due to the increased arterial blood gas monitoring in the nonsurvivor group, an iCa Tw was calculated. All measured iCa values and their corresponding sampling time were taken into account for its calculations. The iCa Tw was calculated assuming a linear trend between individual measurements and giving a time value to such measurements. For example, an iCa of 1.1 mmol/L at 10 AM followed by an iCa of 1.3 at 2 PM, would yield a value of 1.2 mmol/L weighted by 4 hrs. The sum of such weighted values would then be divided by total hours of observation to deliver the iCa Tw for a given individual during ICU admission. The iCa Adm was defined as the first value measured within 24 hrs of ICU admission. As the normal range iCa for each hospital was between 1.15 and 1.25 mmol/L, mild, moderate, and severe hypocalcemia were defined as Ͻ1.15, 0.9, and 0.8 mmol/L, respectively. We also defined mild, moderate, and severe hypercalcemia as Ͼ1.25, 1.35, and 1.45 mmol/L, respectively.
We calculated additional iCa indices for the assessment of fluctuations in iCa. The absolute change in iCa (iCa ␦ ) was calculated as the absolute difference between iCa Max and iCa Min . The percentage relative change in iCa (%iCa ␦ ) was calculated according to the following formula: [(iCa Max Ϫ iCa Min )/iCa Min ] ϫ 100.
Approach to Hypocalcemia and Hypercalcemia in Each Hospital. There was no protocol for intravenous calcium therapy to correct hypocalcemia in the four study hospitals. However, its use was reported to be typically only for severe hypocalcemia associated with bleeding. Intravenous calcium infusion was also used per protocol in patients treated with citrate continuous renal replacement therapy (31) . These patients were excluded from this study and do not appear in our analysis.
Serum Phosphate, Albumin, and Creatinine Measurements. The phosphate and albumin levels were measured every morning by using a phosphomolybdate complex colorimetric technique and a bromcresol purple dye binding colorimetric technique.
Statistical Analysis. The primary outcomes for this analysis were ICU and hospital mortality. Univariate analysis for comparison between groups was performed by using the chisquared test for proportions, Student's t test for normally distributed outcomes, and Wilcoxon's rank sum test for nonparametric data.
Results are reported as means (SD) or medians (interquartile range) as appropriate. As the relationship between iCa and mortality was not linear in nature, iCa was divided into "bands" of 0.1 mmol/L in width and treated as a categorical variable. We defined the iCa reference range for such analyses as being between 1.1 and 1.2 mmol/L in this analysis.
Multivariate analysis was employed with all available predictors of mortality included in the models (gender, age, Acute Physiology and Chronic Health Evaluation II score, mechanical ventilation, surgical admission, and diagnosis type). To determine whether iCa effects were consistent across subgroups, all interactions between measures of iCa and other variables in the model were examined. Results from the multivariate models have been reported by using odds ratios (ORs) with 95% confidence intervals (CIs).
All analysis was performed by using SAS version 9.2 (SAS Institute, Cary, NC). A twosided p value of .05 was considered to be statistically significant.
RESULTS
We studied 7,024 consecutive patients admitted to four ICUs. Their mean age was 61.5 yrs, and their mean Acute Physiology and Chronic Health Evaluation II iCa, ionized calcium concentration; iCa Max , iCa maximum; iCa Min , iCa minimum; iCa Tw , iCa time-weighted average; iCa ␦ , absolute change in iCa; %iCa ␦ , percentage relative change in iCa.
Reported as mean (SD), median (25% quartile and 75% quartile), or n (%). The iCa ␦ was calculated as the absolute difference between iCa Max and iCa Min . The %iCa ␦ was calculated according to the following formula: ͓(iCa Max Ϫ iCa Min )/iCa Min ͔ ϫ 100. score was 17. Of these patients, 43.2% were surgical cases. ICU and hospital mortality were 12.1% and 21.6%, respectively. There were 177,578 iCa measurements with a mean value of 1.11 mmol/L, a minimum of 0.29 mmol/L, and a maximum of 3.32 mmol/L (iCa measured every 4.5 hrs on average).
We detected at least one episode of mild hypocalcemia (Ͻ1.15 mmol/L) in 88.4% of patients, moderate hypocalcemia (Ͻ0.9 mmol/L) in 10.8%, and severe hypocalcemia (Ͻ0.8 mmol/L) in 3.3%. Similarly, we detected mild hypercalcemia (Ͼ1.25 mmol/L) in 22.7% of patients, moderate hypercalcemia (Ͼ1.35 mmol/L) in 6.7%, and severe hypercalcemia (Ͼ1.45 mmol/L) in 2.0%.
When considering patients who had both hypo-and hypercalcemia, 16.9% of patients were found to have both mild hypocalcemia and mild hypercalcemia, while only 1.0% of patients experienced moderate hypocalcemia and moderate hypercalcemia, and only 0.24% were found to have had both severe hypocalcemia and severe hypercalcemia.
Clinical characteristics and the distribution of patients in predefined iCa bands among ICU survivors and nonsurvivors are shown in Table 1 . The iCa Min and iCa Max concentrations were significantly different between ICU survivors and nonsurvivors (p Ͻ .001). The incidence of hypocalcemia and hypercalcemia was significantly higher in nonsurvivors than survivors. The iCa Tw concentrations were also significantly different; however, the strength of the difference was small. There were no statistically significant differences in iCa Adm in nonsurvivor compared with ICU survivors. ; p Ͻ .0001) for iCa levels Ͻ0.80 when compared with patients without such abnormalities. Similar trends were seen for hospital mortality. Severe hypocalcemia was significantly more likely in male, older, and high severity patients with cardiovascular or respiratory failure. We identified 42 patients who experienced extreme hypocalcemia (iCa Ͻ0.7 mmol/L) and con- Reported as mean (SD), median (25% quartile and 75% quartile), or n (%). The iCa ␦ was calculated as the absolute difference between iCa Max and iCa Min . The %iCa ␦ was calculated according to the following formula: ͓(iCa Max Ϫ iCa Min )/iCa Min ͔ ϫ 100.
firmed that only nine of these patients received intravenous calcium.
If hypercalcemia occurred at least once during ICU stay, the probability of ICU mortality increased by 100% for iCa levels Ͼ1. 25 p Ͻ .0001) compared with the cohort without such abnormalities. Similar trends were seen for hospital mortality. Severe hypercalcemia was significantly more likely in male, older, and higher severity patients. It was also significantly more common in postoperative patients. Figures 1-4 show the relationship between each iCa index (iCa Min , iCa Max , iCa Tw , and iCa Adm ) and mortality according to each 0.1-mmol/L band. They all demonstrate that ICU and hospital mortality increased at both extremes but that there was only a small change in mortality for less extreme abnormalities.
Time Course of the iCa in ICU. Among the 229 patients who experienced severe hypocalcemia (Ͻ0. Table 2) .
Relationship of iCa Levels with pH, Serum Phosphate, Albumin-Ionized Magnesium Levels, and Kidney Function. There were 3,219 patients (45.8%) for whom we were able to obtain daily phosphate, albumin, and ionized magnesium levels. The highest serum creatinine concentration during first 24 hrs after ICU admission was also obtained among 4,127 patients (58.8%).
There was a significant, but weak correlation between iCa and pH, phosphate, albumin, and ionized magnesium levels (pH: r ϭ Ϫ.10, p Ͻ .0001; phosphate: r ϭ Ϫ.08, p Ͻ .0001; albumin: r ϭ .14, p Ͻ .0001; ionized magnesium: r ϭ Ϫ.62, p Ͻ .0001).
There was a significant, but weak, correlation between iCa Adm and the highest creatinine level during the first 24 hrs of ICU admission (r ϭ Ϫ.079, p Ͻ .0001).
Multivariate Analysis. After adjustment for other predictors of mortality, there was a significant relationship between iCa Min and ICU and hospital mortality (Table 3 ). This trend was driven by the mortality of patients with very low iCa Min values (Ͻ0.8 mmol/L for ICU mortality and Ͻ0.9 mmol/L for hospital mortality).
There was a significant relationship between hospital and ICU mortality and iCa Max (Table 4 ). This result was again primarily dependent on patients with very high iCa levels (Ͼ ϭ 1.4 mmol/L). The iCa Tw concentration was independently related to mortality (ICU mortality p ϭ .001 and hospital mortality p ϭ .0003) ( Table 5 ). This result was mostly dependent on patients with iCa Tw values Ͻ1.0 mmol/L. Finally, iCa Adm was not significantly related to mortality. As there were no significant interactions between iCa indices and other predictors of mortality, there was no evidence to suggest that their relationship differed across different subgroups.
DISCUSSION
We conducted a four-center retrospective, observational study of Ͼ7,000 patients and 170,000 iCa measurements to investigate the association between iCa concentrations and mortality in critically ill patients. We found that mild hypocalcemia was more common than mild hypercalcemia and that it occurred in close to 90% of patients studied. However, severe hypocalcemia and hypercalcemia were uncommon, occurring in only 2% to 3% of patients. On univariate analysis, hypo-and hypercalcemia were associated with higher mortality; however, after adjusting for other risk factors, the relationship between iCa concentrations and ICU and hospital death was limited in extent and strength and mostly dependent on the effect of extremely high (Ͼ1.4 mmol/L) or extremely low (Ͻ0.9 mmol/L) values.
Before this study, most investigations of hypocalcemia and its association with outcome in ICU patients had been small and single center in nature. In one of the two largest studies, Choi and Hwang (24) studied 255 trauma patients in a single center. They defined mild and severe hypocalcemia as iCa Adm level between 0.89 and 1.14 mmol/L and Ͻ0.89 mmol/L, respectively. By these definitions, mild and severe admission hypocalcemia occurred in 76.5% and 20.8% of patients. Nonsurvivors had significantly lower iCa Adm compared with survivors. On multivariate analysis, an iCa Adm level Ͻ0.88 mmol/L was an independent predictor of mortality. Hästbacka and Pettilä (5) investigated 941 patients in a single center retrospective observational study. They defined mild and severe hypocalcemia as an iCa level between 0.90 and 1.15 mmol/L and Ͻ0.90 mmol/L, respectively, and found that mild and severe hypocalcemia during ICU stay occurred in 85.0% and 10.2% of patients, values that are remarkably similar to ours. Nonsurvivors had significantly lower iCa Adm and iCa Min concentrations. In our study, we confirmed, in a large heterogeneous cohort, that lower iCa levels are associated with unfavorable patient outcomes on univariate analysis. We then performed multivariable analysis to assess the independent association between hypocalcemia and mortality. We found an independent but weak association between iCa Min and iCa Max and a stronger and more significant relationship between iCa Tw and ICU and hospital mortality. However, most of this association was driven by patients with extreme hypocalcemia. There are even fewer published studies that assess the incidence and association of hypercalcemia in critically ill patients. Forster et al (27) reported hypercalcemia (iCa Ͼ1.33 mmol/L) in 15 of 100 (15%) surgical ICU patients with no difference in mortality reported between patients with or without hypercalcemia. Zaloga et al (1) reported hypercalcemia (total serum Ca Ͼ10.5 mg/dl or iCa Ͼ1.27 mmol/L) in 8% of 156 surgical/medical intensive care patients with no difference in mortality between patients with or without hypercalcemia. No studies have assessed the independent relationship between ionized hypercalcemia and outcome. Our observations demonstrate that, using a variety of indices, ionized hypercalcemia has an association with ICU and hospital mortality, which is similar in strength to that of ionized hypocalcemia.
Hypocalcemia of critical illness has been treated with calcium chloride (29) . However, intravenous calcium administration might cause skin necrosis (37) , cardiac arrhythmias (38, 39) , and cellular injury (40, 41) . Furthermore, calcium administration has been reported to increase mortality in septic animal models (30, 42) . Despite the high incidence of hypocalcaemia, there is no randomized controlled trial to assess the risks and benefits of calcium supplementation in hypocalcemic critically ill patients; it is therefore unclear whether hypocalcemia (mild/moderate or even severe in the absence of clinical signs) should be treated.
By demonstrating an almost symmetrical U-shaped relationship between iCa levels and ICU and hospital mortality with weak independent association out- side of extreme low and high range, our findings suggest that disorders in ionized calcemia are most likely to represent levels of physiologic derangements, which reflect underlying illness severity (marker of illness severity). Such weak association differs in both nature, internal coherence, and strength from that seen, for example, with indices of glycemia (47-50) and does not logically justify specific interventions to treat iCa (except, perhaps, at extremes). Until randomized controlled study become available, no correction of ionized calcium, at least between 0.9 and 1.4 mmol/L, appears physiologically or clinically rational. In many centers, iCa values are now typically and automatically included in arterial blood gas measurement reports, even though they are not the driving force to sampling. Our data may be useful to clinicians in appreciating the mortality rates associated with certain level of iCa. Such information can be incorporated in the decision making process as additional markers of prognosis.
The causes of abnormalities in iCa are not clearly understood. Some have described an association with altered parathyroid hormone levels (9, 43) . In this study, we were not able to observe parathyroid hormone level. It is also possible that changes in phosphate levels would affect iCa levels. In about half of our cohort, daily phosphate levels were available to assess any such link and only a weak relationship was found.
A possible explanation for the relationship between iCa concentration and outcome might relate to a possible effect of hypercalcemia on kidney dysfunction in critically ill patients (44) . However, iCa levels at admission had only a very weak association with serum creatinine in the first 24 hrs. These findings suggest that abnormalities of iCa might occur because of multiple factors and might only be markers of acute illness rather than contributors to morbidity (45, 46) .
There are limitations in this study. Our study is retrospective in design and thus potentially subject to systematic error and bias. However, the clinical and electronic data were collected prospectively, are numerical in nature, and were measured independently; thus they were not amenable to selection bias or unintended manipulation. We studied only four centers, and our findings may not be generalizable. However, we note that all other studies of iCa so far have been single center in design and that our study is one order of magnitude greater than previous investigations.
Furthermore, there is no information of citrate infusion accompanied with blood transfusion, which might affect our results. Data on such confounding factors should be collected in further prospective studies.
To our knowledge, this study is the largest and first multicenter examination of the epidemiology and outcome associations of hypo-and hypercalcemia. Our observations are in broad agreement with the literature for hypocalcemia and expand our understanding of hypercalcemia. Although the clinical benefits and safety of correcting high or low iCa levels can only be fully assessed in a randomized controlled trial, until such time, our findings also have practical implications.
In summary, in a large, heterogeneous, multicenter cohort of critically ill patients, we found a limited, independent, U-shaped association between ionized hypo-and hypercalcemia and mortality. We also found that this association was mostly dependent on patients with extremely low or high iCa levels. Our results suggest that abnormalities of iCa concentrations are likely a marker of illness severity rather than an independent contributor to mortality, especially for levels between 0.9 and 1.4 mmol/L. For these patients no correction of iCa appears physiologically or clinically rational. Further studies now appear desirable to confirm or refute our observations.
